Page 720 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 720

Chapter 42  Sickle Cell Disease  607.e5


            200.  Buchanan GR, Glader BE: Benign course of extreme hyperbilirubine-  227.  Koshy M, Entsuah R, Koranda A, et al: Leg ulcers in patients with sickle
                mia in sickle cell anemia: analysis of six cases. J Pediatr 91:21, 1977.  cell disease. Blood 74:1403, 1989.
            201.  Kindscher  JD,  Laurin  J,  Delcore  R,  et al:  Liver  transplantation  in  a   228.  Cackovic M, Chung C, Bolton LL, et al: Leg ulceration in the sickle
                patient with sickle cell anemia. Transplantation 60:762, 1995.  cell patient. J Am Coll Surg 187:307, 1998.
            202.  Swaim MW, Agarwal S, Rosse WF: Successful treatment of hepatitis C   229.  Koshy M, Entsuah R, Koranda A, et al: Leg ulcers in patients with sickle
                in sickle-cell disease. Ann Intern Med 133:750, 2000.  cell disease. Blood 74:1403, 1989.
            203.  Koshy M: Sickle cell disease and pregnancy. Blood Rev 9:157, 1995.  230.  Schleucher R, Gaessler M, Knobloch J: Rapid healing of a late diagnosed
            204.  Hassell K: Pregnancy and sickle cell disease. Hematol Oncol Clin North   sickle cell leg ulcer using a new combination of treatment methods.
                Am 19:903, 2005.                                      J Wound Care 16:197, 2007.
            205.  Manchikanti A, Grimes DA, Lopez LM, et al: Steroid hormones for   231.  Keidan AJ, Stuart J: Rheological effects of bed rest in sickle cell disease.
                contraception in women with sickle cell disease. Cochrane Database Syst   J Clin Pathol 40:1187, 1987.
                Rev (2):CD006261, 2007.                           232.  Sher  GD,  Olivieri  NF:  Rapid  healing  of  chronic  leg  ulcers  during
            206.  Molitierno JA, Jr, Carson CC, III: Urologic manifestations of hema-  arginine butyrate therapy in patients with sickle cell disease and thalas-
                tologic disease sickle cell, leukemia, and thromboembolic disease. Urol   semia. Blood 84:2378, 1994.
                Clin North Am 30:49, 2003.                        233.  Covitz  W,  Espeland  M,  Gallagher  D,  et al: The  heart  in  sickle  cell
            207.  Abbott KC, Hypolite IO, Agodoa LY: Sickle cell nephropathy at end-  anemia. The Cooperative Study of Sickle Cell Disease (CSSCD). Chest
                stage  renal  disease  in  the  United  States:  patient  characteristics  and   108:1214, 1995.
                survival. Clin Nephrol 58:9, 2002.                234.  Miller DM, Winslow RM, Klein HG, et al: Improved exercise perfor-
            208.  Perneger TV, Whelton PK, Klag MJ: Risk of kidney failure associated   mance after exchange transfusion in subjects with sickle cell anemia.
                with the use of acetaminophen, aspirin, and nonsteroidal antiinflam-  Blood 56:1127, 1980.
                matory drugs. N Engl J Med 331:1675, 1994.        235.  Martin CR, Johnson CS, Cobb C, et al: Myocardial infarction in sickle
            209.  Powars DR, Elliott-Mills DD, Chan L, et al: Chronic renal failure in   cell disease. J Natl Med Assoc 88:428, 1996.
                sickle cell disease: risk factors, clinical course, and mortality. Ann Intern   236.  Romero Mestre JC, Hernandez A, Agramonte O, et al: Cardiovascular
                Med 115:614, 1991.                                    autonomic dysfunction in sickle cell anemia: a possible risk factor for
            210.  Pariser S, Katz A: Treatment of sickle cell trait hematuria with oral urea.   sudden death? Clin Auton Res 7:121, 1997.
                J Urol 151:401, 1994.                             237.  Hassell KL, Eckman JR, Lane PA: Acute multiorgan failure syndrome: a
            211.  Falk  RJ,  Scheinman  J,  Phillips  G,  et al:  Prevalence  and  pathologic   potentially catastrophic complication of severe sickle cell pain episodes.
                features  of  sickle  cell  nephropathy  and  response  to  inhibition  of   Am J Med 96:155, 1994.
                angiotensin-converting enzyme. N Engl J Med 326:910, 1992.  238.  Kumar S, Powars D, Allen J, et al: Anxiety, self-concept, and personal
            212.  Foucan L, Bourhis V, Bangou J, et al: A randomized trial of captopril   and  social  adjustments  in  children  with  sickle  cell  anemia.  J  Pediatr
                for microalbuminuria in normotensive adults with sickle cell anemia.   88:859, 1976.
                Am J Med 104:339, 1998.                           239.  Vichinsky  EP,  Johnson  R,  Lubin  BH:  Multidisciplinary  approach  to
            213.  Batlle D, Itsarayoungyuen K, Arruda JA, et al: Hyperkalemic hyper-  pain management in sickle cell disease. Am J Pediatr Hematol Oncol
                chloremic metabolic acidosis in sickle cell hemoglobinopathies. Am J   4:328, 1982.
                Med 72:188, 1982.                                 240.  Platt OS, Rosenstock W, Espeland MA: Influence of sickle hemoglo-
            214.  Davis CJ, Jr, Mostofi FK, Sesterhenn IA: Renal medullary carcinoma.   binopathies on growth and development. N Engl J Med 311:7, 1984.
                The seventh sickle cell nephropathy. Am J Surg Pathol 19:1, 1995.  241.  Hankins  JS,  Ware  RE,  Rogers  ZR,  et al:  Long-term  hydroxyurea
            215.  Adeyoju AB, Olujohungbe AB, Morris J, et al: Priapism in sickle-cell   therapy  for  infants  with  sickle  cell  anemia:  the  HUSOFT  extension
                disease;  incidence,  risk  factors  and  complications—An  international   study. Blood 106:2269, 2005.
                multicentre study. BJU Int 90:898, 2002.          242.  Prasad AS, Cossack ZT: Zinc supplementation and growth in sickle cell
            216.  Baruchel S, Rees J, Bernstein ML, et al: Relief of sickle cell priapism   disease. Ann Intern Med 100:367, 1984.
                by hydralazine. Report of a case. Am J Pediatr Hematol Oncol 15:115,   243.  Heyman MB, Vichinsky E, Katz R, et al: Growth retardation in sickle-
                1993.                                                 cell disease treated by nutritional support. Lancet 1:903, 1985.
            217.  Dahm P, Rao DS, Donatucci CF: Antiandrogens in the treatment of   244.  Badaloo AV, Singhal A, Forrester TE, et al: The effect of splenectomy
                priapism. Urology 59:138, 2002.                       for hypersplenism on whole body protein turnover, resting metabolic
            218.  Levine  LA,  Guss  SP:  Gonadotropin-releasing  hormone  analogues  in   rate and growth in sickle cell disease. Eur J Clin Nutr 50:672, 1996.
                the treatment of sickle cell anemia-associated priapism. J Urol 150:475,   245.  Lane PA, Githens JH: Splenic syndrome at mountain altitudes in sickle
                1993.                                                 cell trait. Its occurrence in nonblack persons. JAMA 253:2251, 1985.
            219.  Rogers ZR: Priapism in sickle cell disease. Hematol Oncol Clin North   246.  Diggs LW: The sickle cell trait in relation to the training and assignment
                Am 19:917, viii, 2005.                                of duties in the armed forces: III. Hyposthenuria, hematuria, sudden
            220.  Fowler JE, Jr, Koshy M, Strub M, et al: Priapism associated with the   death, rhabdomyolysis, and acute tubular necrosis. Aviat Space Environ
                sickle cell hemoglobinopathies: prevalence, natural history and sequelae.   Med 55:358, 1984.
                J Urol 145:65, 1991.                              247.  Gonzalez-Redondo JM, Kutlar A, Kutlar F, et al: Molecular character-
            221.  Emerson GG, Lutty GA: Effects of sickle cell disease on the eye: clinical   ization of Hb S(C) β-thalassemia in American Blacks. Am J Hematol
                features  and  treatment.  Hematol  Oncol  Clin  North  Am  19:957,  ix,   38:9, 1991.
                2005.                                             248.  Christakis J, Vavatsi N, Hassapopoulou H, et al: A comparison of sickle
            222.  Stevens MC, Padwick M, Serjeant GR: Observations on the natural   cell syndromes in northern Greece. Br J Haematol 77:386, 1991.
                history  of  dactylitis  in  homozygous  sickle  cell  disease.  Clin  Pediatr   249.  Serjeant  GR,  Sommereux  AM,  Stevenson  M,  et al:  Comparison  of
                (Phila) 20:311, 1981.                                 sickle  cell-β°  thalassemia  and  homozygous  sickle  cell  disease.  Br  J
            223.  Aguilar C, Vichinsky E, Neumayr L: Bone and joint disease in sickle   Haematol 41:83, 1979.
                cell disease. Hematol Oncol Clin North Am 19:929, viii, 2005.  250.  Serjeant GR, Serjeant BE: Comparison of sickle cell-β° thalassemia and
                                                                             +
            224.  Hutchinson RM, Merrick MV, White JM: Fat embolism in sickle cell   sickle cell-β  thalassemia in Black populations. In Cao A, Carcassi U,
                disease. J Clin Pathol 26:620, 1973.                  Rowley  PT,  editors:  Thalassemia:  Advances  in  detection  and  treatment.
            225.  Clare  A,  FitzHenley  M,  Harris  J,  et al:  Chronic  leg  ulceration  in   Birth Defects Original Article Series, New York, 1982, Alan R. Liss, p 233.
                homozygous sickle cell disease: the role of venous incompetence. Br J   251.  Friedman  S,  Schwartz  E,  Ahern  E,  et al:  Variations  in  globin  chain
                Haematol 119:567, 2002.                               synthesis in hereditary persistence of fetal hemoglobin. Br J Haematol
            226.  Kato GJ, McGowan V, Machado RF, et al: Lactate dehydrogenase as a   32:357, 1976.
                biomarker of hemolysis-associated nitric oxide resistance, priapism, leg   252.  Dozy AM, Kan YW, Embury SH, et al: Alpha-globin gene organisa-
                ulceration, pulmonary hypertension, and death in patients with sickle   tion in blacks precludes the severe form of alpha-thalassaemia. Nature
                cell disease. Blood 107:2279, 2006.                   280:605, 1979.
   715   716   717   718   719   720   721   722   723   724   725